INM InMed Pharmaceuticals Inc. - Common Shares
$1,56
Cena · Sie 19, 2026
Dane fundamentalne na dzień Maj 6, 2026
Zakres 52 tyg.
$1–$2
51% of range
Ocena Analityków
SELL
8 analysts
Cena Docelowa
—
P/E (TTM)
-0.4
ROE
—
Marża Zysku Netto
—
INM Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$1.56
Kapitalizacja Rynkowa
—
P/E (TTM)
-0.4
EPS (TTM)
$-8.36
Przychody (TTM)
$5M
Stopa dywidendy
—
ROE
—
D/E Dług/Kapitał
—
Zakres 52 tyg.
$1 – $3
INM Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$5M
2022-06-30
→
2025-06-30
EPS
$-8.36
2021-06-30
→
2025-06-30
Wolny przepływ pieniężny
—
2021-06-30
→
2024-06-30
Marże
—
2024-06-30
→
2024-06-30
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
INM
Mediana porównawcza
P/E (TTM)
-0.4
32.2
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
INM
Mediana porównawcza
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
INM
Mediana porównawcza
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
INM
Mediana porównawcza
Revenue YoY (Przychody R/R)
7.5%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
65.5%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
INM
Mediana porównawcza
INM Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
SPRZEDAJ
8 analityków
- Mocne kupno 0 0,0%
- Kup 0 0,0%
- Trzymaj 3 37,5%
- Sprzedaj 4 50,0%
- Mocna sprzedaż 1 12,5%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-169.5%
Następny raport
Wrz 21, 2026
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 września 2025 | $-1.94 | — | — |
| 30 czerwca 2024 | $-0.19 | — | — |
| 31 marca 2024 | $-0.76 | — | — |
| 30 czerwca 2022 | $-280.60 | $-111.10 | -169.5% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $5M | $5M | $4M | $1M | |
| Cost of Revenue | $3M | $3M | $3M | $545.9K | |
| Gross Profit | $2M | $1M | $1M | $543.5K | |
| R&D Expense | $3M | $3M | $4M | $7M | |
| SG&A Expense | $7M | $6M | $6M | $7M | |
| Operating Expenses | $10M | $9M | $10M | $18M | |
| Operating Income | · | · | $-8M | $-19M | |
| Interest Income | $155.9K | $527.9K | $492.4K | $96.1K | |
| Other Non-op | · | $527.9K | $492.4K | $-1M | |
| Pretax Income | $-8M | $-8M | $-8M | $-19M | |
| Income Tax | · | $7.1K | $13.1K | · | |
| Net Income | $-8M | $-8M | $-8M | $-19M | |
| EPS (Basic) | $-8.36 | $-20.14 | $-3.25 | $-33.17 | |
| EPS (Diluted) | $-8.36 | $-20.14 | $-3.25 | $-33.17 | |
| Shares (Basic) | 975,985 | 381,053 | 2,448,458 | 560,829 | |
| Shares (Diluted) | 975,985 | 381,053 | 2,448,458 | 560,829 | |
| EBITDA | · | $219.6K | · | · |
Bilans 24
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $7M | $9M | $6M | |
| Short-term Investments | $43.4K | $43.1K | $44.4K | $44.8K | |
| Receivables | $465.1K | $352.8K | $260.4K | $88.0K | |
| Inventory | $961.2K | $1M | $2M | $2M | |
| Prepaid Expense | $319.5K | $477.7K | $498.0K | $797.2K | |
| Current Assets | $13M | $9M | $11M | $10M | |
| PP&E (Net) | $992.2K | $1M | $723.4K | $904.3K | |
| PP&E (Gross) | $2M | $3M | $2M | $1M | |
| Accum. Depreciation | $1M | $1M | $925.3K | $516.5K | |
| Intangibles | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $100.0K | $100.0K | $104.9K | $176.6K | |
| Total Assets | $16M | $12M | $14M | $13M | |
| Accounts Payable | $1M | $2M | · | $2M | |
| Accrued Liabilities | · | $256.5K | $357.7K | · | |
| Current Liabilities | $2M | $2M | $2M | $3M | |
| Capital Leases | $305.8K | $644.9K | $16.0K | $389.5K | |
| Total Liabilities | $2M | $3M | $2M | $4M | |
| Common Stock | $91M | $83M | $78M | $71M | |
| Paid-in Capital | · | · | $36M | $32M | |
| Retained Earnings | $-117M | $-109M | $-101M | $-93M | |
| AOCI | $128.6K | $128.6K | $128.6K | $128.6K | |
| Stockholders' Equity | $13M | $9M | $12M | $9M | |
| Liabilities + Equity | $16M | $12M | $14M | $13M | |
| Shares Outstanding | 2,002,186 | 445,908 | 166,370 | 650,667 |
Przepływy pieniężne 11
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $212.8K | $219.6K | $202.2K | $185.7K | |
| Stock-based Comp | $119.3K | $137.7K | $278.2K | $697.9K | |
| Amort. of Intangibles | $162.6K | $171.9K | $159.2K | $159.2K | |
| Other Non-cash | · | $332.4K | · | · | |
| Operating Cash Flow | $-8M | $-7M | $-7M | $-16M | |
| CapEx | · | $9.3K | $160.0K | $39.1K | |
| Investing Cash Flow | · | $-9.3K | $-661.8K | $-673.0K | |
| Stock Issued | · | · | $12M | $17M | |
| Financing Cash Flow | $12M | $5M | $11M | $15M | |
| Net Change in Cash | · | $-2M | $3M | $-1M | |
| Free Cash Flow | · | $-7M | · | · |
Rentowność 6
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | · | 23.9% | · | · | |
| Net Margin | · | -166.9% | · | · | |
| Pretax Margin | · | -166.8% | · | · | |
| EBITDA Margin | · | 4.8% | · | · | |
| ROA | · | -59.2% | · | · | |
| ROE | · | -75.6% | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | · | 4.4 | · | · | |
| Quick Ratio | · | 3.5 | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | · | 0.4 | · | · | |
| Inventory Turnover | · | 2.4 | · | · | |
| Receivables Turnover | · | 15.0 | · | · |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 7.5% | 11.2% | 279.6% | · | |
| Revenue CAGR 3Y | 65.5% | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $5M | $5M | $4M | $1M | |
| Net Income TTM | $-8M | $-8M | $-8M | $-19M | |
| Market Cap | · | $47M | · | · | |
| P/E | -0.4 | -0.3 | -5.7 | -7.1 | |
| P/S | · | 10.3 | · | · | |
| P/B | · | 5.2 | · | · | |
| P / Tangible Book | 0.6 | 6.4 | 6.1 | 21.9 | |
| P / Cash Flow | · | -6.8 | · | · | |
| P / FCF | · | -6.8 | · | · | |
| Earnings Yield | -257.2% | -378.6% | -17.5% | -14.1% |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $820.2K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $901.9K | $2M | $1M | $469.8K | $320.8K | $514.8K | |
| Cost of Revenue | · | $636.0K | $717.0K | $728.1K | $1M | $650.8K | $771.2K | $817.0K | $883.1K | $916.1K | $880.6K | $1M | $841.4K | $338.6K | $235.0K | $265.0K | |
| Gross Profit | · | $184.2K | $403.2K | $576.7K | $175.6K | $460.9K | $493.4K | $466.1K | $289.5K | $324.1K | $21.2K | $2M | $192.5K | $131.2K | $-491.0K | $249.7K | |
| R&D Expense | $1M | $630.6K | $581.6K | $348.9K | $425.4K | $895.2K | $700.1K | $658.9K | $656.8K | $609.8K | $1M | $623.7K | $878.3K | $851.4K | $1M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | |
| Operating Expenses | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $7M | |
| Operating Income | · | · | · | · | · | · | · | · | · | · | $-3M | · | $-2M | $-2M | $-4M | $-8M | |
| Interest Income | $47.8K | $74.4K | $93.8K | $51.7K | $16.6K | $30.5K | $57.1K | $103.6K | $121.5K | $166.8K | $136.0K | $148.6K | $155.5K | $115.8K | $72.6K | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $136.0K | · | · | · | $65.8K | · | |
| Pretax Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | $-2M | $-1M | $-3M | $-336.6K | $-2M | $-2M | $-4M | $-8M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.8K | · | |
| Net Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | $-2M | $-1M | $-3M | $-338.4K | $-2M | $-2M | $-4M | $-8M | |
| EPS (Basic) | $-0.73 | $-0.51 | $-0.44 | $-0.07 | $-1.94 | $-3.64 | $-2.71 | $2.39 | $-3.58 | $-3.71 | $-15.24 | $2.32 | $-0.60 | $-0.91 | $-4.06 | $-13.13 | |
| EPS (Diluted) | $-0.73 | $-0.51 | $-0.44 | $-0.07 | $-1.94 | $-3.64 | $-2.71 | $2.39 | $-3.58 | $-3.71 | $-15.24 | $2.32 | $-0.60 | $-0.91 | $-4.06 | $-13.13 | |
| Shares (Basic) | 4,048,209 | 3,954,549 | 3,954,549 | -1,446,661 | 1,095,973 | 706,546 | 620,127 | -664,679 | 480,649 | 398,673 | 166,410 | -4,045,878 | 3,328,191 | 2,300,526 | 865,619 | -1,041,029 | |
| Shares (Diluted) | 4,048,209 | 3,954,549 | 3,954,549 | -1,446,661 | 1,095,973 | 706,546 | 620,127 | -664,679 | 480,649 | 398,673 | 166,410 | -4,045,878 | 3,328,191 | 2,300,526 | 865,619 | -1,041,029 | |
| EBITDA | · | · | $53.2K | · | · | · | $54.6K | · | · | · | $-2M | · | $-2M | $-2M | $-3M | · |
Bilans 24
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $7M | $9M | $11M | $5M | $3M | $6M | $7M | $8M | $10M | $7M | $9M | $10M | $11M | $9M | $6M | |
| Short-term Investments | $41.6K | $42.7K | $42.9K | $43.4K | $40.6K | $40.8K | $43.2K | $43.1K | $43.1K | $44.5K | $42.9K | $44.4K | $43.1K | $43.1K | $42.1K | $44.8K | |
| Receivables | · | $183.0K | $343.5K | $465.1K | $367.8K | $262.6K | $284.7K | $352.8K | $207.7K | $372.9K | $165.8K | $260.4K | $170.3K | $81.6K | $15.2K | $88.0K | |
| Inventory | · | $947.9K | $890.8K | $961.2K | $814.0K | $1M | $1M | $1M | $1M | $744.8K | $1M | $2M | $1M | $2M | $2M | $2M | |
| Prepaid Expense | $617.2K | $660.3K | $191.8K | $321.7K | $507.9K | $644.0K | $148.9K | $477.7K | $1M | $1M | $215.0K | $498.0K | $695.2K | $826.9K | $356.7K | $797.2K | |
| Current Assets | $7M | $9M | $11M | $13M | $6M | $5M | $7M | $9M | $10M | $12M | $8M | $11M | $12M | $14M | $12M | $10M | |
| PP&E (Net) | $642.9K | $764.3K | $881.5K | $992.2K | $1M | $1M | $1M | $1M | $1M | $1M | $615.1K | $723.4K | $753.2K | $703.9K | $802.4K | · | |
| PP&E (Gross) | · | · | · | $2M | $2M | $2M | $2M | $3M | $3M | · | $2M | $2M | $2M | $1M | $1M | $1M | |
| Accum. Depreciation | · | · | · | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $925.3K | $819.3K | $716.8K | $618.4K | $516.5K | |
| Intangibles | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $104.4K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $101.8K | $104.9K | $147.5K | $171.1K | $171.1K | $176.6K | |
| Total Assets | $9M | $11M | $13M | $16M | $9M | $9M | $10M | $12M | $13M | $15M | $11M | $14M | $15M | $17M | $15M | $13M | |
| Accounts Payable | $1M | $1M | $1M | $1M | $1M | $1M | $2.0K | $2M | $1M | $1M | $1M | · | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | · | · | $85.5K | · | $167.5K | $100.4K | · | $357.7K | · | · | · | · | |
| Current Liabilities | $2M | $1M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $3M | $3M | |
| Capital Leases | $30.8K | $123.8K | $215.5K | $305.8K | $419.3K | $529.2K | $633.8K | $644.9K | $725.2K | $802.8K | · | $16.0K | $72.8K | $183.9K | $294.3K | $389.5K | |
| Total Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $1M | $2M | $2M | $3M | $4M | $4M | |
| Common Stock | $93M | $92M | $92M | $91M | $87M | $85M | $84M | $83M | $81M | $80M | $78M | $78M | $78M | $75M | $73M | $71M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $38M | · | · | $36M | $38M | $35M | $32M | |
| Retained Earnings | $-124M | $-121M | $-119M | $-117M | $-115M | $-113M | $-111M | $-109M | $-107M | $-105M | $-104M | $-101M | $-101M | $-99M | $-97M | $-93M | |
| AOCI | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | |
| Stockholders' Equity | $7M | $10M | $12M | $13M | $7M | $6M | $8M | $9M | $11M | $13M | $10M | $12M | $12M | $14M | $11M | $9M | |
| Liabilities + Equity | $9M | $11M | $13M | $16M | $9M | $9M | $10M | $12M | $13M | $15M | $11M | $14M | $15M | $17M | $15M | $13M | |
| Shares Outstanding | 3,314,063 | 2,804,186 | 2,604,186 | 2,002,186 | 1,207,186 | 724,152 | 667,013 | 445,908 | 6,344,970 | 5,667,970 | 3,328,191 | 3,328,191 | 3,328,191 | 1,589,992 | 908,766 | 650,667 |
Przepływy pieniężne 12
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $50.5K | $53.2K | $53.2K | $52.8K | $52.3K | $53.2K | $54.6K | $54.8K | $54.8K | $55.2K | $54.8K | $53.5K | $50.7K | $49.0K | $49.0K | $54.0K | |
| Stock-based Comp | $38.8K | $25.3K | $20.2K | $26.7K | $40.5K | $23.2K | $29.0K | $39.0K | $55.3K | $18.3K | $25.2K | $40.5K | $50.4K | $70.6K | $116.7K | · | |
| Amort. of Intangibles | $41.0K | $41.0K | $41.0K | $40.5K | $41.0K | $41.0K | $41.0K | $48.9K | $41.0K | $41.0K | $41.0K | $37.1K | $40.1K | $41.0K | $41.0K | · | |
| Other Non-cash | · | · | $45.9K | · | · | · | $-232.5K | · | · | · | $282.6K | · | · | · | $1M | · | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-1M | $-2M | $-2M | $-2M | $-657.9K | $-2M | $-3M | $-2M | $-4M | |
| CapEx | · | · | · | · | · | · | · | $0 | $2 | · | · | $31.8K | · | · | · | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $-2 | · | · | $-33.6K | $-128.2K | · | · | $-725.5K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | $174 | $6M | $6M | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | · | |
| Financing Cash Flow | $231.7K | $0 | $-137.2K | $8M | $3M | $338.5K | $838.2K | $176 | $0 | · | · | $0 | $-63.7K | $5M | $5M | $5M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-2M | · | · | $-691.5K | $-2M | $2M | $3M | $278.6K | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.8K | · |
Rentowność 7
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 22.5% | 36.0% | · | 13.9% | 41.5% | 39.0% | · | 24.7% | 26.1% | 2.4% | · | 18.6% | 27.9% | -153.1% | · | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | -281.3% | · | -193.2% | -447.2% | -1094.2% | · | |
| Net Margin | · | -247.3% | -154.2% | · | -168.1% | -231.6% | -132.7% | · | -146.9% | -119.2% | -281.3% | · | -193.2% | -447.2% | -1094.2% | · | |
| Pretax Margin | · | -247.3% | -154.2% | · | -168.1% | -231.6% | -132.7% | · | -146.9% | -119.2% | -281.3% | · | -193.1% | -446.6% | -1092.1% | · | |
| EBITDA Margin | · | · | 4.8% | · | · | · | 4.3% | · | · | · | -275.2% | · | -193.2% | -447.2% | -1079.0% | · | |
| ROA | -32.2% | -20.6% | -14.5% | · | -18.7% | -21.7% | -15.7% | · | -12.3% | -9.2% | -19.9% | · | -13.2% | -11.6% | -22.0% | · | |
| ROE | -42.6% | -25.7% | -17.3% | · | -23.4% | -27.2% | -18.7% | · | -14.7% | -10.9% | -24.6% | · | -17.2% | -14.7% | -26.8% | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | 5.9 | 6.9 | · | 3.5 | 3.1 | 5.1 | · | 6.6 | 7.0 | 6.2 | · | 5.2 | 5.8 | 3.5 | · | |
| Quick Ratio | 2.4 | 4.9 | 6.2 | · | 2.8 | 2.1 | 4.1 | · | 5.1 | 5.9 | 5.2 | · | 4.3 | 4.8 | 2.9 | · |
Efektywność 3
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | |
| Inventory Turnover | · | 0.6 | 0.7 | · | 1.1 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.5 | · | 0.6 | 0.3 | 0.3 | · | |
| Receivables Turnover | · | 3.7 | 3.6 | · | 4.4 | 3.5 | 5.6 | · | 6.2 | 5.5 | 10.0 | · | 8.6 | 7.1 | 21.4 | · |
Wycena (TTM) 9
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | $5M | · | $5M | $5M | $5M | · | $4M | $4M | $3M | · | $2M | $1M | · | · | |
| Net Income TTM | $-9M | $-8M | $-8M | · | $-8M | $-7M | $-7M | · | $-8M | $-8M | $-10M | · | $-11M | $-13M | $-14M | · | |
| Market Cap | $2M | $3M | $6M | · | $2M | $3M | $3M | · | $46M | $47M | $47M | · | $72M | $64M | $120M | · | |
| P/E | -0.2 | -0.2 | -0.3 | · | -0.2 | -0.3 | -0.2 | · | -0.3 | -0.4 | -0.7 | · | -1.8 | -2.1 | -5.5 | · | |
| P/S | 0.5 | 0.7 | 1.2 | · | 0.5 | 0.7 | 0.7 | · | 10.6 | 12.9 | 17.1 | · | 33.7 | 47.1 | · | · | |
| P/B | 0.3 | 0.3 | 0.5 | · | 0.4 | 0.6 | 0.4 | · | 4.2 | 3.7 | 4.9 | · | 5.8 | 4.5 | 10.9 | · | |
| P / Tangible Book | 0.4 | 0.4 | 0.6 | · | 0.5 | 0.8 | 0.5 | · | 5.0 | 4.3 | 6.1 | · | 6.9 | 5.2 | 13.4 | · | |
| P / Cash Flow | · | · | -3.5 | · | · | · | -1.7 | · | · | · | -21.4 | · | · | · | -53.1 | · | |
| Earnings Yield | -561.2% | -616.0% | -398.6% | · | -573.4% | -287.8% | -532.5% | · | -317.7% | -245.9% | -148.6% | · | -54.2% | -46.6% | -18.3% | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| Przychody | $5M | $5M | $4M | $1M | — |
| Marża Brutto % | — | 23.9% | — | — | — |
| Zysk netto | $-8M | $-8M | $-8M | $-19M | $-10M |
| Rozwodniony EPS | $-8.36 | $-20.14 | $-3.25 | $-33.17 | $-37.96 |
Bilans
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | — | 4.4 | — | — | 3.8 |
| Wskaźnik Szybkości | — | 3.5 | — | — | 3.4 |
Przepływy pieniężne
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | — | $-7M | — | — | $-10M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 21 emitentów · $4.1M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 13 (+9 vs poprzedni kw.) | 2 (0 vs poprzedni kw.) | 0 (-2 vs poprzedni kw.) | 3 (+3 vs poprzedni kw.) | +2.4M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | $1 240 000 | 800 000 | 29,90% | Akcje |
| Vivo Capital, LLC | $1 237 484 | 798 377 | 29,84% | Akcje |
| Squadron Capital Management LLC | $503 750 | 325 000 | 12,15% | Akcje |
| Ikarian Capital, LLC | $379 788 | 245 025 | 9,16% | Akcje |
| Ursa Fund Management, LLC | $194 990 | 125 800 | 4,70% | Akcje |
| MONTANOVA CAPITAL, LLC | $155 000 | 100 000 | 3,74% | Akcje |
| BOOTHBAY FUND MANAGEMENT, LLC | $115 078 | 74 244 | 2,77% | Akcje |
| SABBY MANAGEMENT, LLC | $69 704 | 44 970 | 1,68% | Akcje |
| Venrock Adviser, LLC | $50 662 | 32 685 | 1,22% | Akcje |
| CITADEL ADVISORS LLC | $40 430 | 26 084 | 0,97% | Akcje |
| SEVEN GRAND MANAGERS, LLC | $38 750 | 25 000 | 0,93% | Akcje |
| JANE STREET GROUP, LLC | $32 057 | 20 682 | 0,77% | Akcje |
| Scientech Research LLC | $23 965 | 15 461 | 0,58% | Akcje |
| Crestwood Advisors Group, LLC | $23 095 | 14 900 | 0,56% | Akcje |
| TWO SIGMA SECURITIES, LLC | $16 965 | 10 945 | 0,41% | Akcje |
| Stratos Wealth Partners, LTD. | $16 678 | 10 760 | 0,40% | Akcje |
| Private Wealth Management Group, LLC | $7 750 | 5 000 | 0,19% | Akcje |
| Banque Cantonale Vaudoise | $1 000 | 6 | 0,02% | Akcje |
| SBI Securities Co., Ltd. | $465 | 300 | 0,01% | Akcje |
| Federation des caisses Desjardins du Quebec | $2 | 1 | 0,00% | Akcje |
| AllSquare Wealth Management LLC | $2 | 1 | 0,00% | Akcje |
Insiderzy spółki 18 insiderów · 8 dyrektorzy generalni · 10 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Eric A Adams | President & CEO | 19 grudnia 2025 A | 43 959 | 0 | 0 | $0 |
| Netta Jagpal | Chief Financial Officer | 19 grudnia 2025 A | — | 0 | 0 | $0 |
| Jonathan Tegge | Interim CFO | 23 grudnia 2023 A | — | 0 | 0 | $0 |
| Bruce Colwill | CFO | 24 stycznia 2022 P | 11 515 | 0 | 0 | $0 |
| Michael Woudenberg | Chief Operating Officer | 19 grudnia 2025 A | — | 0 | 0 | $0 |
| Shane Aaron Johnson | Sr VP & General Manager | 19 grudnia 2025 A | 304 595 | 0 | 0 | $0 |
| Eric C Hsu | Sr. VP, Pre-Clinical Res/Dev | 19 grudnia 2025 A | — | 0 | 0 | $0 |
| Sarah Li | VP Accounting & Controller | 16 grudnia 2022 A | — | 0 | 0 | $0 |
| John Steven Bathery | Dyrektor | 19 grudnia 2025 A | — | 0 | 0 | $0 |
| Nicole Lemerond | Dyrektor | 19 grudnia 2025 A | — | 0 | 0 | $0 |
| Andrew Hull | Dyrektor | 19 grudnia 2025 A | 38 258 | 0 | 0 | $0 |
| Neil A Klompas | Dyrektor | 19 grudnia 2025 A | — | 0 | 0 | $0 |
| Bryan T Baldasare | Dyrektor | 20 grudnia 2024 A | — | 0 | 0 | $0 |
| Janet P Grove | Dyrektor | 20 grudnia 2024 A | — | 0 | 0 | $0 |
| Adam D. Cutler | Dyrektor | 24 stycznia 2022 H | — | 0 | 0 | $0 |
| William J Garner | Dyrektor | 24 stycznia 2022 H | — | 0 | 0 | $0 |
| Catherine Sazdanoff | Dyrektor | 29 grudnia 2021 A | — | 0 | 0 | $0 |
| Alexandra Diane Janet Mancini | — | 31 lipca 2024 S | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity, LLC, Vivo Opportunity Cayman Fund, L.P., Vivo Opportunity Cayman, LLC | 10 czerwca 2026 | 21,70% | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.